Skip to Content

BMS 6081 (Metaglip 2.5 mg / 250 mg)

Generic Name: glipizide/metformin

Pill imprint BMS 6081 has been identified as Metaglip 2.5 mg / 250 mg.

Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 2.5 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Metaglip 2.5 mg / 250 mg BMS 6081
Metaglip 2.5 mg / 250 mg BMS 6081 Front
Metaglip 2.5 mg / 250 mg BMS 6081 Back
Discount Card Promo
Metaglip
Generic Name:
glipizide/metformin
Imprint:
BMS 6081
Strength:
2.5 mg / 250 mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00087-6081

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide